全文获取类型
收费全文 | 1041篇 |
免费 | 45篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 36篇 |
妇产科学 | 5篇 |
基础医学 | 93篇 |
口腔科学 | 47篇 |
临床医学 | 90篇 |
内科学 | 198篇 |
皮肤病学 | 58篇 |
神经病学 | 24篇 |
特种医学 | 39篇 |
外科学 | 172篇 |
综合类 | 21篇 |
预防医学 | 37篇 |
眼科学 | 51篇 |
药学 | 142篇 |
1篇 | |
中国医学 | 13篇 |
肿瘤学 | 55篇 |
出版年
2024年 | 2篇 |
2023年 | 9篇 |
2022年 | 44篇 |
2021年 | 66篇 |
2020年 | 18篇 |
2019年 | 17篇 |
2018年 | 24篇 |
2017年 | 22篇 |
2016年 | 35篇 |
2015年 | 31篇 |
2014年 | 54篇 |
2013年 | 55篇 |
2012年 | 105篇 |
2011年 | 88篇 |
2010年 | 49篇 |
2009年 | 30篇 |
2008年 | 57篇 |
2007年 | 72篇 |
2006年 | 59篇 |
2005年 | 45篇 |
2004年 | 29篇 |
2003年 | 39篇 |
2002年 | 47篇 |
2001年 | 20篇 |
2000年 | 15篇 |
1999年 | 13篇 |
1998年 | 5篇 |
1997年 | 6篇 |
1996年 | 2篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1968年 | 1篇 |
1915年 | 1篇 |
排序方式: 共有1087条查询结果,搜索用时 15 毫秒
1.
2.
Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteers. 总被引:1,自引:0,他引:1
Y S R Krishnaiah R S Karthikeyan P Bhaskar V Satyanarayana 《Journal of controlled release》2002,83(2):231-239
Guar gum-based three-layer matrix tablets of a highly water-soluble drug, trimetazidine dihydrochloride, were evaluated for their in vivo release in healthy volunteers in comparison with commercially available conventional immediate release tablets. Six healthy volunteers participated in the study and a two-way crossover design was followed. The plasma concentration of trimetazidine dihydrochloride was estimated by reverse-phase HPLC. The pharmacokinetic parameters were calculated from the plasma concentration of trimetazidine dihydrochloride versus time data. The delayed T(max), decreased C(max) and K(a), unaltered bioavailability, and prolonged t(1/2) and MRT indicated a slow and prolonged release of trimetazidine dihydrochloride from guar gum three-layer matrix tablets in comparison with the immediate release tablet dosage form. The guar gum three-layer matrix tablets of trimetazidine dihydrochloride may be useful in providing constant drug delivery with minimum fluctuations. 相似文献
3.
4.
5.
6.
New approaches to preventing restenosis 总被引:1,自引:0,他引:1
Balram Bhargava Ganesan Karthikeyan Alexandre S Abizaid Roxana Mehran 《British medical journal》2003,327(7409):274-279
7.
S M Al-Saidan Y S R Krishnaiah V Satyanarayana P Bhaskar R S Karthikeyan 《European journal of pharmaceutics and biopharmaceutics》2004,58(3):697-703
The objective of the present study is to carry out pharmacokinetic evaluation of oral controlled release formulation (guar gum-based three-layer matrix tablets) containing highly soluble metoprolol tartrate as a model drug. Six healthy volunteers participated in the study, and a two-way crossover design was followed. The plasma concentration of metoprolol tartrate was estimated by reverse-phase HPLC. The pharmacokinetic parameters were calculated from the plasma concentration of metoprolol tartrate versus time data. The delayed T(max) lower C(max) decreased K(a) unaltered bioavailability and prolonged t(1/2) indicated a slow and prolonged release of metoprolol tartrate from guar gum three-layer matrix tablets in comparison with the immediate release tablet dosage form. The results of the study indicated that guar gum three-layer matrix tablets were able to provide oral controlled delivery of highly water-soluble drug such as metoprolol tartrate in humans. 相似文献
8.
Neelam Runda Souvik Manna Murugesan Vanathi Radhika Tandon Noopur Gupta 《Indian journal of ophthalmology》2022,70(6):1963
Purpose:To compare the efficacy of physiological, non-detergent eyelid wipes with conventional lid hygiene in patients with meibomian gland dysfunction (MGD).Methods:Fifty participants with MGD were recruited and randomized into two groups. Participants in group I used Evolve Pure™ Eyewipes twice a day to clean the eyelid debris along with standard therapy (antibiotic and lubricants) and participants in group II followed lid hygiene with warm compresses along with standard therapy. Symptoms, ocular surface assessment (lipid layer thickness, tear meniscus height, non-invasive tear film breakup time, and meibography), slit-lamp biomicroscopy (eyelash contamination, meibomian gland blockage, meibomian gland secretion, and meibomian gland telangiectasia) and tear film osmolarity were noted at baseline and 90 days after therapy.Results:Significant improvement in symptoms and signs of MGD was observed in both groups after treatment (P < 0.001); however, the clinical improvement was better with the use of eyelid wipes. Lipid layer thickness increased significantly in group I (P = 0.0006) and group II (P = 0.0002), which was maintained even after adjusting for sociodemographic variables such as age, sex, and severity score of symptoms and signs.Conclusion:Lipid layer thickness of the tear film is a sensitive marker in monitoring response to treatment in patients with MGD. The use of physiological detergent-free eyelid wipes is non-inferior to lid hygiene and warm compresses, which remains the mainstay for treatment of MGD; the clinical improvement with eyelid wipes was noted to be better. 相似文献
9.
Richard S P Huang Julie Y Tse Lukas Harries Ryon P Graf Douglas I Lin Karthikeyan Murugesan Matthew C Hiemenz Vamsi Parimi Tyler Janovitz Brennan Decker Eric Severson Mia A Levy Shakti H Ramkissoon Julia A Elvin Jeffrey S Ross Erik A Williams 《The oncologist》2022,27(8):655
BackgroundIn the current study, we examined the real-world prevalence of highly pigmented advanced melanomas (HPMel) and the clinicopathologic, genomic, and ICPI biomarker signatures of this class of tumors.Materials and MethodsOur case archive of clinical melanoma samples for which the ordering physician requested testing for both PD-L1 immunohistochemistry (IHC) and comprehensive genomic profiling (CGP) was screened for HPMel cases, as well as for non-pigmented or lightly pigmented advanced melanoma cases (LPMel).ResultsOf the 1268 consecutive melanoma biopsies in our archive that had been submitted for PD-L1 IHC, 13.0% (165/1268) were HPMel and 87.0% (1103/1268) were LPMel. In the HPMel cohort, we saw a significantly lower tumor mutational burden (TMB, median 8.8 mutations/Mb) than in the LPMel group (11.4 mut/Mb), although there was substantial overlap. In examining characteristic secondary genomic alterations (GA), we found that the frequencies of GA in TERTp, CDKN2A, TP53, and PTEN were significantly lower in the HPMel cases than in LPMel. A higher rate of GA in CTNNB1, APC, PRKAR1A, and KIT was identified in the HPMel cohort compared with LPMel.ConclusionsIn this study, we quantified the failure rates of melanoma samples for PD-L1 testing due to high melanin pigmentation and showed that CGP can be used in these patients to identify biomarkers that can guide treatment decisions for HPMel patients. Using this practical clinical definition for tumor pigmentation, our results indicate that HPMel are frequent at 13% of melanoma samples, and in general appear molecularly less developed, with a lower TMB and less frequent secondary GA of melanoma progression. 相似文献
10.